Dario to Participate in Craig-Hallum and BTIG Digital Health
DarioHealth Corp. (Nasdaq: DRIO) announced participation in two upcoming investor conferences.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
DarioHealth Corp. (Nasdaq: DRIO) announced participation in two upcoming investor conferences. The 13th Annual Craig-Hallum Alpha Select Conference will take place on November 17, 2022, in New York City, featuring investor one-on-one meetings. Additionally, the BTIG Digital Health Forum is scheduled for November 21, 2022, as a virtual event, where President Rick Anderson will discuss digital therapeutics at 11:55 a.m. EST. DarioHealth focuses on digital solutions for chronic condition management, delivering personalized care through analytics and coaching.
Details
News Market Reaction – DRIO
The recorded move for DRIO in the trading session of this news was +5.09%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NEW YORK, Nov. 16, 2022 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) (the "Company"), a leader in the global digital therapeutics (DTx) market, announced today that management will participate at the following conferences:
13th Annual Craig-Hallum Alpha Select Conference
Format: Investor one-on-one meetings
Date: Thursday, November 17, 2022
Location: New York City, NY
BTIG Digital Health Forum
Format: Investor one-on-one meetings
Date: November 21, 2022
Location: Virtual
Rick Anderson, President of Dario, will participate in the panel discussion "Moving Digital Devices and Therapeutics into the Mainstream" at 11:55 a.m. EST.
For more information, please visit Craig-Hallum.com and BTIG.com.
About DarioHealth Corp.
DarioHealth Corp. (Nasdaq: DRIO) is a leading digital therapeutics (DTx) company revolutionizing how people with chronic conditions manage their health through a user-centric multi-chronic condition platform. Our platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
Our user-centric platform offers people continuous and customized care for health, disrupting the traditional episodic approach to healthcare. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention, and results. Making the right thing to do the easy thing to do.
Dario provides its highly user rated solutions globally to health plans and other payors, self-insured employers, providers of care and directly to consumers. To learn more about DarioHealth and its digital health solutions, or for more information, visit http://dariohealth.com.
DarioHealth Corporate Contact
Mary Mooney
VP Marketing
mary@dariohealth.com
+1-312-593-4280
Media Contact:
Scott Stachowiak
Scott.Stachowiak@russopartnersllc.com
+1-646-942-5630
Logo - https://mma.prnewswire.com/media/1920436/DarioHealth_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/dario-to-participate-in-craig-hallum-and-btig-digital-health-301679910.html
SOURCE DarioHealth Corp.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.